Polar Capital Holdings PLC Regeneron Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

$18.6 Billion
Q3 2025

A detailed history of Polar Capital Holdings PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 158,817 shares of REGN stock, worth $110 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

158,817

Previous 70,000 126.88%

Holding current value

$110 Million

Previous $36.8 Million 142.99%

% of portfolio

0.48%

Previous 0.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$534.91 - $598.71 $47.5 Million - $53.2 Million	88,817 Added 126.88%	158,817 $89.3 Million
Q2 2025 Aug 14, 2025	BUY	$483.07 - $625.6 $7.25 Million - $9.38 Million	15,000 Added 27.27%	70,000 $36.8 Million
Q1 2025 May 15, 2025	SELL	$634.14 - $744.83 $792,040 - $930,292	-1,249 Reduced 2.22%	55,000 $34.9 Million
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $10.9 Million - $16.3 Million	-15,546 Reduced 21.65%	56,249 $40.1 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $62.7 Million - $73.6 Million	-61,236 Reduced 46.03%	71,795 $75.5 Million

Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $38.8 Million - $47.1 Million	-43,927 Reduced 24.82%	133,031 $140 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $18.9 Million - $20.8 Million	-20,889 Reduced 10.56%	176,958 $170 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $50.7 Million - $57.6 Million	65,347 Added 49.32%	197,847 $174 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $10.2 Million - $12.4 Million	15,000 Added 12.77%	132,500 $109 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $3.53 Million - $3.83 Million	5,000 Added 4.44%	117,500 $84.8 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $7.17 Million - $9.05 Million	-12,500 Reduced 10.0%	112,500 $77.5 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $11 Million - $14.8 Million	-20,000 Reduced 13.79%	125,000 $73.9 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $14.9 Million - $17.5 Million	-25,000 Reduced 14.71%	145,000 $101 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $11.5 Million - $13.6 Million	20,000 Added 13.33%	170,000 $103 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $35.5 Million - $41.9 Million	75,000 Added 100.0%	150,000 $83.8 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $8.93 Million - $11 Million	-20,000 Reduced 21.05%	75,000 $35.5 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $45.4 Million - $57.8 Million	95,000 New	95,000 $45.9 Million

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Regeneron Pharmaceuticals, Inc. Transaction History